ALKBH5 and hepatocellular carcinoma: Here, we report for the first time that the alterations of METTL16 and ALKBH5 are closely associated with worse clinical characteristics including survival, and loss of METTL16 is an independent risk factor of DFS, suggesting their potential roles in HCC carcinogenesis and progression.